For two weeks, try keeping a simple diary of: What you drink and eat: Note the timing and types of beverages
When Cold-Turkey Cessation Is Medically Contraindicated Abrupt GLP-1 discontinuation is contraindicated in patients with uncontrolled diabetes, recent weight loss, or ongoing metabolic instability
Weight loss is known to trigger compensatory biology: Increased appetite signaling Reduced resting energy expenditure Heightened food reward sensitivity Stopping GLP-1 therapy at peak dose, without tapering and without reinforcing lifestyle strategies at the exact moment hunger returns, does not allow lifestyle behaviors to take over. Emerging real-world data and obesity physiology suggest a different, more clinically relevant path: Gradual dose reduction rather than abrupt cessation Continued, structured dietary and exercise support Active monitoring during the high-risk post-cessation period We still need randomized trials designed specifically to test tapering and lifestyle-anchored maintenance strategies
Psychosocial stress and cervical neoplasia risk
Yes, the program can be adjusted or discontinued based on your progress and goals, with guidance from your healthcare provider to ensure a proper transition.
Yatsunenko T, Rey FE, Manary MJ, Trehan I, Dominguez-Bello MG, Contreras M et al (2012) Human gut microbiome viewed across age and geography
